retatrutide type 2 diabetes phase 2 results 2024 2025 UK Guide: Key Facts on the New Weight-Loss Drug Retatrutide UK 2026: Phase 3

Daniel Drucker, Lunenfeld-Tanenbaum Research Institute Zarghami still wishes that the GLP-1 approach to weight loss had worked for her

Approval process was quick and easy

Oral semaglutide (Rybelsus) requires 14mg dosing to achieve similar blood levels as 2.4mg injectable semaglutide

Early evidence suggests that individuals using GLP-1s spend significantly less money at the grocery store, shifting their purchasing habits away from snacks, alcohol, and carbohydrates while also increasing demand for high-protein and nutrient-dense foods (e.g., Roe, 2025

Glutathione adds antioxidant support

The OASIS 4 trial found that patients taking the oral Wegovy pill lost an average of 13.6% of their body weight over 64 weeks, while the STEP 1 trial for injectable Wegovy showed 14.9% weight loss over 68 weeks